-
Signature
-
/s/ Joseph Theis, attorney-in-fact
-
Stock symbol
-
HUBS
-
Transactions as of
-
May 20, 2025
-
Transactions value $
-
-$4,267,440
-
Form type
-
4
-
Date filed
-
5/21/2025, 04:08 PM
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Halligan Brian |
Director |
C/O HUBSPOT, INC., 2 CANAL PARK, CAMBRIDGE |
/s/ Joseph Theis, attorney-in-fact |
2025-05-21 |
0001603527 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
HUBS |
Common Stock |
Options Exercise |
$325K |
+2.9K |
+0.55% |
$112.15 |
529K |
May 20, 2025 |
Direct |
F1 |
| transaction |
HUBS |
Common Stock |
Options Exercise |
$895K |
+5.6K |
+1.06% |
$159.70 |
534K |
May 20, 2025 |
Direct |
F1 |
| transaction |
HUBS |
Common Stock |
Sale |
-$5.49M |
-8.5K |
-1.59% |
$645.54 |
526K |
May 20, 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
HUBS |
Stock Option (right to buy) |
Options Exercise |
$0 |
-2.9K |
-100% |
$0.00 |
0 |
May 20, 2025 |
Common Stock |
2.9K |
$112.15 |
Direct |
F2 |
| transaction |
HUBS |
Stock Option (right to buy) |
Options Exercise |
$0 |
-5.6K |
-39.31% |
$0.00 |
8.65K |
May 20, 2025 |
Common Stock |
5.6K |
$159.70 |
Direct |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: